4578:TSEOtsuka Holdings Co., Ltd. Analysis
Data as of 2026-03-10 - not real-time
¥10,190.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Otsuka Holdings posted an 8.4% revenue increase in FY25 and lifted profit, backed by a gross margin of 71.7% and operating cash flow of ¥403 bn, leaving a comfortable cash pile of ¥535 bn. The dividend payout ratio sits at just 20% with a 1.42% yield, underscoring the sustainability of its shareholder return.
On the price side, the stock trades at ¥10,190, just below its 20‑day SMA (¥10,275) but comfortably above the 50‑day (¥9,596) and 200‑day (¥8,266) averages. RSI is neutral at 53.8 and the MACD histogram is negative, signalling short‑term bearish momentum. Valuation is mixed: a forward PE of 19.6 is higher than the current 14.9, yet the company’s PE is well below the industry average of 25.4, and the DCF fair value of ¥7,739 suggests the market may be pricing in a premium of roughly 7%.
On the price side, the stock trades at ¥10,190, just below its 20‑day SMA (¥10,275) but comfortably above the 50‑day (¥9,596) and 200‑day (¥8,266) averages. RSI is neutral at 53.8 and the MACD histogram is negative, signalling short‑term bearish momentum. Valuation is mixed: a forward PE of 19.6 is higher than the current 14.9, yet the company’s PE is well below the industry average of 25.4, and the DCF fair value of ¥7,739 suggests the market may be pricing in a premium of roughly 7%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just below the 20‑day SMA
- Bearish MACD histogram indicating potential pull‑back
- Stable volume and low beta limiting market‑wide shocks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings growth and expanding profit margins
- Undervalued relative to industry PE multiple
- Target median price of ¥10,800 offering ~6% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversified pharmaceutical and nutraceutical pipeline
- Robust cash generation and low payout ratio supporting dividend sustainability
- Resilient business model with modest debt relative to cash holdings
Key Metrics & Analysis
Financial Health
Revenue Growth8.40%
Profit Margin14.71%
P/E Ratio14.9
ROE12.46%
ROA7.46%
Debt/Equity7.36
P/B Ratio1.8
Op. Cash Flow¥403.6B
Free Cash Flow¥191.0B
Industry P/E25.4
Technical Analysis
TrendBullish
RSI53.8
Support¥9,499.00
Resistance¥10,910.00
MA 20¥10,275.20
MA 50¥9,595.84
MA 200¥8,266.18
MACDBearish
VolumeStable
Fear & Greed Index80.36
Valuation
Fair Value¥7,738.55
Target Price¥10,933.33
Upside/Downside7.29%
GradeFair
TypeBlend
Dividend Yield1.42%
Risk Assessment
Beta0.32
Volatility36.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.